48Hour Discovery receives Government of Canada funding to develop technology that maximizes success of drug discovery

New technology platform would deliver orally available small molecule therapeutics for a wide range of targets EDMONTON, ALBERTA (April 18, 2019) – 48Hour Discovery (48HD) today announced that it will  receive up to $193,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to research and develop a technology that expedites drugs discovery and development. The novel streamlined platform would potentially deliver stable drug-like molecules with proven efficacy and membrane permeability, which directly provides an advantage for clients to accelerate through the Food and Drug Administration (FDA)’s Investigational New Drug Program (IND). Finding therapeutic compounds…

View article


Precision Therapeutics’ subsidiary TumorGenesis and its partner 48Hour Discovery Inc. receive Alberta Innovates Product Demonstration Program grant to support development of novel cancer treatments

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) – Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD), a Canadian partner, in receiving a $300,000 CAD grant through the Alberta Innovates Product Demonstration Program. The strategic collaboration will commercialize TumorGenesis’ Oncology Discovery Platform Kits, with a set of proprietary reagents from 48HD’s core technology to inform personalized treatment decisions in cancer treatments. The development of the TumorGenesis Oncology Discovery Platform Kits…

View article


48Hour Discovery names industry veteran John Dwyer as the company’s new Vice President of Research

EDMONTON, ALBERTA (April 15, 2019) – 48Hour Discovery INC., a biotechnology company focused on the discovery of peptide-derived small molecule therapeutics, is pleased to welcome Dr. John Dwyer as its new Vice President of Research. This is a key step in the Canadian company’s efforts to drive growth and expand its R&D department. Dwyer brings over 20 years of expertise from the pharmaceutical industry. He was most recently the Director of Protein Engineering at Ferring Pharmaceuticals at their US headquarters. He and his team were responsible for early drug discovery projects focused in oncology and endocrinology, and Dwyer was…

View article


48Hour Discovery announces the appointment of David Alton as Director of Business Development

EDMONTON, ALBERTA (March 11, 2019) – 48Hour Discovery Inc. announced the appointment of David Alton as the Director of Business Development, effective March 11, 2019. Alton will bring extensive experience in leadership to the management team, strengthen the Company’s business infrastructure and develop new investment opportunities. “We are excited to have David join our team as the Director of Business Development,” says Samantha Kwok, Operations Manager of 48Hour Discovery. “David brings valuable insight in building a company and managing the pitfalls of growth.” Alton has over 10 years of experience in the biotechnology sector, predominantly in marketing and financing. Most…

View article


48Hour Discovery proud to sponsor the Canadian Glycomics Symposium 2018

EDMONTON (April 17 2018)–48Hour Discovery Inc. (48HD) is pleased to announce a sponsorship with the Canadian Glycomics Network (GlycoNet) to support the Canadian Glycomics Symposium 2018. The Symposium affords an exciting opportunity to glimpse the frontiers of knowledge in the emerging field of glycomics. This annual Symposium welcomes more than 200 researchers, trainees, and stakeholders in the fields of glycomics, biotechnology, and pharmaceuticals. The Symposium will feature presentations from notable national and international experts in carbohydrate science, as well as an open forum for young scientists to highlight their research. “We are thrilled to be a sponsor for the Symposium…

View article


Join Us for an Inside Look of our Technology

Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting new technology and will involve hands-on experiments and real-time data analysis. The workshop will describe how you can leverage our molecular discovery pipeline for your own research endeavors. Purchase tickets here!

View article


GlycoNet Agreement with 48Hour Discovery

“We are extremely pleased to see a core service being commercialized… Supporting 48Hour Discovery fits with our strategic goals of spurring job creation and fostering start-up success in Canada.” said Dr. Todd Lowary, GlycoNet Scientific Director. To see full article, click here

View article


Highlight of 48Hour Discovery in the Edmonton Journal

Our company was recently highlighted in the Edmonton Journal: Edmonton startup wants to put Alberta at epicentre of molecular discoveries A University of Alberta biotechnology spinoff wants to put Edmonton at the epicentre of molecular discoveries by creating an immense searchable database that could speed up and drive down the cost of research and development. To read the full article, click here.  

View article